GlassScriptPhysician profile
Christopher Robert Lumley
NPI 1669678793
$14,936.30
in general payments reported to CMS, 2019-2025
45 companies · $2,533 in 2025
The $2,533 reported for 2025 was more than what 86% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,768 · 2020: $1,815 · 2021: $1,608 · 2022: $1,766 · 2023: $1,678 · 2024: $2,768 · 2025: $2,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,979.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,574.71 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mentor Worldwide LLC | $1,363.58 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Kerecis Limited | $1,078.76 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $937.28 | 2019-2025 | Renasys Touch, Pico 7 |
| Allergan, INC. | $904.27 | 2019-2022 | |
| Sientra, INC. | $828.10 | 2020-2022 | |
| Abbvie INC. | $813.19 | 2023-2025 | |
| Tela Bio, INC. | $666.12 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Axogen | $496.50 | 2019-2023 | Avance Nerve Graft |
| Depuy Synthes Sales INC. | $473.62 | 2020-2025 | Trumatch, Na, Matrixorthognathic |
| Misonix INC | $393.94 | 2019-2021 | |
| Kls-Martin L.P. | $321.99 | 2019-2025 | |
| Polynovo North America LLC | $316.56 | 2023-2025 | Novosorb Btm |
| Stryker Corporation | $249.34 | 2020-2024 | Hydroset, Na, Conextions Tr Tendon Repair System-Implant Mechanism |
| Musculoskeletal Transplant Foundation INC. | $245.11 | 2019-2023 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $244.18 | 2024 | |
| Ethicon US, LLC | $233.92 | 2019-2022 | |
| Medtronic, INC. | $232.26 | 2022-2025 | V-Loc 180 |
| Tepha INC | $210.11 | 2019 | |
| Davol INC. | $185.78 | 2019-2025 | Arista |
| Organogenesis INC. | $171.24 | 2024-2025 | Puraply Franchise, Puraply Wound Matrix |
| Solventum Corporation | $170.89 | 2025 | Prevena |
| Baxter Healthcare | $170.33 | 2021-2025 | Artiss |
| Checkpoint Surgical, INC | $156.72 | 2021-2023 | Checkpoint Stimulators |
| Urgo Medical North America, LLC | $155.36 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Acell, INC. | $152.00 | 2019-2020 | |
| Heron Therapeutics, INC. | $146.13 | 2025 | Zynrelef |
| Bard Peripheral Vascular, INC. | $141.58 | 2021 | |
| Biotissue Holdings INC. | $131.98 | 2025 | |
| Mimedx Group, INC. | $127.89 | 2025 | |
| Tei Biosciences INC | $96.47 | 2019 | |
| Avita Medical Americas, LLC | $83.20 | 2024 | |
| Trimed, INC. | $74.58 | 2021 | |
| Galderma Laboratories, L.P. | $64.88 | 2019 | |
| Bioventus LLC | $50.97 | 2022-2023 | Theragenesis Bilayer Wound Matrix |
| Becton, Dickinson and Company | $48.19 | 2025 | Phasix Mesh |
| Rti Surgical, INC | $39.15 | 2023-2025 | |
| Apyx Medical Corporation | $31.47 | 2019 | |
| Sanara Medtech INC. | $30.45 | 2024 | Celleraterx |
| Merz North America, INC. | $22.98 | 2019 | |
| Polarityte, INC. | $22.32 | 2019 | |
| W. L. Gore & Associates, INC. | $21.22 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Medela LLC | $20.86 | 2020 | |
| Lifenet Health | $18.67 | 2023-2024 | Theragenesis Wound Matrix |
| Motiva USA, LLC | $17.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lumley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.